[Treatment of infection in bone-marrow insufficiency].
D000380:Agranulocytosis / Q000150:complications; D000667:Ampicillin / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000150:complications; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D001855:Bone Marrow Diseases / Q000150:complications*; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use
D005839:Gentamicins; D010406:Penicillins; D011113:Polymyxins; D007612:Kanamycin; D000667:Ampicillin; D002228:Carbenicillin; D002512:Cephalothin; D010068:Oxacillin
Infektionstherapie bei knochenmarkinsuffizienz